News Daily News Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo L.A. McKeown August 24, 2016
News Opinion Editor's Corner ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness Shelley Wood August 24, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Daily News CLEAN-TAVI: Se Publican los Resultados de Protección Embólica Cerebral en TAVR Yael L. Maxwell August 15, 2016
News Opinion Fellow Talk Top 10 Tricks on Financial Planning for Fellows Yael L. Maxwell August 09, 2016
News Daily News Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR Michael O'Riordan July 25, 2016
News Daily News Decline Seen in Readmissions After PCI in the Medicare Population Todd Neale July 21, 2016
News Daily News Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print Yael L. Maxwell July 12, 2016
News Opinion Conversations in Cardiology Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient? July 11, 2016
News Daily News Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality Michael O'Riordan June 23, 2016
News Daily News La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año Michael O'Riordan June 23, 2016
News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
News Conference News TVT 2016 Teenage TAVR: Should Practice Forge on While Guidelines Grow Up? Michael O'Riordan June 20, 2016
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Features Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent Caitlin E. Cox June 17, 2016
Presentation TVT 2016 Study Design for the PARTNER 3 Low-Risk Trial Presenter: Martin B. Leon June 16, 2016